Showing results (281-290 of 361) with videos related to
Sort By:
Pageof 37
The New England Journal of Medicine|May 1, 1998
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'ImmunothérapieS Negrier, B Escudier, C Lasset, et al.Cancer Genetics and Cytogenetics|October 1, 1987
Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patientsR Berger, A Bernheim, M E Ochoa-Noguera, et al.Presse Medicale (Paris, France : 1983)|July 14, 1984
[Hodgkin's disease. Residual histologically stable masses after chemotherapy]E Lepage, C Ferme, J Frija, et al.Annales De Medecine Interne|January 1, 1988
[Collection of blood stem cells and therapeutic applications]J Reiffers, J M Boiron, G Marit, et al.Gene Therapy|February 26, 2003
Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patientsF Griscelli, P Opolon, P Saulnier, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma GroupQ G van Hoesel, J Verweij, G Catimel, et al.Cancer Research|June 15, 1991
No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myelomaC Duperray, R Bataille, J M Boiron, et al.Anticancer Research|January 1, 1981
Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trialD F Chiuten, G J Vosika, M T Shaw, et al.La Nouvelle Presse Medicale|July 14, 1979
[Stage III and VI Hodgkin's disease. Success and failure of therapeutic protocol H2 65 (author's transl)]C Jacquillat, G Auclerc, J P Desprez-Curely, et al.Leukemia & Lymphoma|November 9, 2001
A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropeniaF Bauduer, T Cousin, O Boulat, et al.Pageof 37